
Nano-X Imaging (NNOX) Stock Forecast & Price Target
Nano-X Imaging (NNOX) Analyst Ratings
Bulls say
Nano X Imaging Ltd. has demonstrated a positive financial trajectory, with quarterly revenue increasing to $3.4 million from $3.0 million in the previous quarter, fueled by enhanced teleradiology utilization and improved operational margins. The company has reaffirmed its objective to exceed 100 deployed units globally by year-end and has provided forward-looking revenue guidance of $35 million for 2026, indicating strong confidence in its growth potential across various revenue channels. Additionally, a strategic partnership with 3DR Labs to distribute its AI imaging solutions in North America significantly enhances Nanox's market presence, further supporting the expansion of its imaging ecosystem and future commercialization efforts.
Bears say
Nano X Imaging Ltd has experienced a significant decline in cash reserves, with total cash decreasing from $83.2 million at year-end to $55.5 million, driven by an operational cash burn of $30.4 million. The company's revenue growth expectations have been consistently lowered over the past year, indicating ongoing challenges in achieving financial targets. Furthermore, the elevated GAAP gross loss of $2.9 million persists alongside a stable net loss of $13.7 million, underscoring continued heavy investment in system deployments and AI infrastructure without corresponding revenue growth.
This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.
Nano-X Imaging (NNOX) Analyst Forecast & Price Prediction
Start investing in Nano-X Imaging (NNOX)
Order type
Buy in
Order amount
Est. shares
0 shares